The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
Journal of Ethnopharmacology(2020)
摘要
Image 1
更多查看译文
关键词
Epigallocatechin gallate (EGCG),5,3′,4′,3″,4″,5″-6-O-ethyl-EGCG (Y6),Daunorubicin (DNR),Cardiotoxicity,Antitumor effect,Human carbonyl reductase 1 (CBR1)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络